| Literature DB >> 32821422 |
Charlotte Arp Sørensen1,2,3, Charlotte Olesen1,4, Marianne Lisby3,5, Ulrika Enemark6, Annette de Thurah3,7.
Abstract
BACKGROUND: Self-administration of medication (SAM) during hospitalization is a complex intervention where patients are involved in their course of treatment. The study aim was to pilot test the SAM intervention. The objectives were to assess the feasibility of conducting a randomized controlled trial on the safety and cost-consequences of SAM during hospitalization.Entities:
Keywords: Clinical safety; Feasibility; Medication error; Patient involvement; Self-administration; Self-management
Year: 2020 PMID: 32821422 PMCID: PMC7433129 DOI: 10.1186/s40814-020-00665-3
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Fig. 1Workflows. (a) By assessing the appearance, container, labeling, identification of content, storage conditions, and expiration [16]. (b) Medication to the patient was delivered from the medicine room as the smallest/cheapest original package. (c) eMAR, electronic Medication Administration Record. An arrow on the circle indicates that the process can be repeated depending on medication changes and the patient’s length of hospital stay
Error types
| Error type | Definition |
|---|---|
| Wrong medication | The dispensed medication was not prescribed in the eMAR. |
| Omission of dose | The prescribed dose of the medication was not dispensed to the patient. |
| Wrong dose | The dose deviated from the prescribed dose. |
| Wrong administration form | The form of the dispensed medication deviated from the eMAR prescription. |
| Wrong strength per unit | The strength of the dispensed medication deviated from the prescription in the eMAR. For example, 1 tablet of 100 mg was prescribed in the eMAR but 2 tablets of 50 mg were dispensed. If this deviation was not documented in the eMAR, it was regarded a procedural error. |
| Lack of documentation of a substitution | A substitution was made but not documented in the eMAR. |
| Lack of documentation of the dispensing | The medication was not documented as “dispensed” in the eMAR. |
Sources: relevant error types derived from the literature [4, 5, 27]
Summary—assessment of the 12 methodological issues for feasibility studies
| Methodological issues | Findings | Evidence |
|---|---|---|
| 1) Did the feasibility/pilot study allow a sample size calculation for the main trial? | Achieved from the error rate in the control group. | Error proportion 16.1% Sample size: observation of 1020 OEs per group |
| 2) What factors influenced eligibility and what proportion of those approached was eligible? | Ineligibility was mainly due to the following: patients not being capable of self-administration, not self-administering at home, and capable but not bringing own medications. | 153/441 patients assessed were eligible, see Fig. |
| 3) Was recruitment successful? | Recruitment was satisfactory. | 60 patients were recruited within 3 months as planned. |
| 4) Did eligible participants consent? | Invited patients consented. | 10/70 patients declined |
| 5) Were participants successfully randomized and did randomization yield equality in groups? | Participants were successfully randomized with equality in groups. | No statistically significant differences between groups, e.g., gender ( |
| 6) Did participants adhere to the intervention? | Good adherence, but not all procedures worked in clinical practice (participants = nurses). | Nurses delivered less medication to patients in the intervention group than planned. Nurses did not remove the “self-administration status” from the eMAR at discharge as planned |
| 7) Was the intervention acceptable to the participants? | The intervention was well accepted by patients. | Highly satisfied—91.7% I; 66.7% C Prefer future SAM—94.4% I; 66.7% C |
| 8) Was it possible to calculate intervention costs and duration? | Further details in the calculation of costs and time measurements must be taken into account. Recruitment period was estimated to be 14 months. | Time used on other tasks than medication dispensing, administration, and SAM start must be measured. |
| 9) Were outcome assessments completed? | Main areas of interest were assessed. | Dispensing errors were observed in both groups with an error proportion of 3.4% in the intervention group and 16.1% in the control group. See Table |
| 10) Were outcomes measured those that were the most appropriate outcomes? | Primary outcome was appropriate. It would be relevant to add secondary outcomes of SAM’s effects after discharge, e.g., perceptions regarding medication. | The proportion of dispensing errors in relation to OEs in total is appropriate as primary outcome for the safety of SAM. |
| 11) Was retention to the study good? | Retention was good. | Response rate follow-up—92.3 % I; 100 % C |
| 12) Did all components of the protocol work together? | The overall protocol worked as planned. Few adjustments were considered. | Adjustments were considered for exclusion criteria, recruitment procedure, intervention, and outcome methods (see numbers 1, 6, and 8 in this table) |
I intervention, C control
Sources: methodological issues based on and presented in the order of the work of Shanyinde et al. [24] and Bugge et al. [25]
Baseline characteristics and observation of dispensing
| Intervention, | Control, | |
|---|---|---|
| Proportion males, number (%) | 26 (67) | 6 (67) |
| Age, mean (SD) | 64.8 (11.7) | 65.8 (11.9) |
| Lives alone, number (%) | 16 (41) | 1(11) |
| Proportion “no medication prior to admission,” number (%) | 5 (12) | 1 (11) |
| Number of medication at admission, mean (SD) | 5.6 (4.2) | 2.6 (1.5) |
| Number of medication at discharge, mean (SD) | 7.8 (3.4) | 7.4 (2.3) |
| Length of stay, median (SD) | 3.2 (2.0) | 2.7 (1.4) |
| Cardiology patient, number (%) | 31 (79) | 7 (78) |
| | ||
| Patients where dispensing was observed 1 time, number | 39 | 9 |
| Patients where dispensing was observed 2 times, number | 25 | 2 |
| Patients where dispensing was observed 3 times, number | 14 | 2 |
| Patients where dispensing was observed 4 times, number | 8 | 1 |
| | ||
| OEs, total number | 348 | 56 |
| OEs at observation 1, mean (range) | 4.6 (1–9) | 4.3 (1–9) |
| | ||
| Total, number (%) | 12 (3.4) | 9 (16.1) |
| Clinical errors, number (%) | 12 (3.4) | 0 |
| Procedural errors, number (%) | Not checked | 9 (16.1) |
| | ||
| Omission, number | 5 | 0 |
| Wrong dose, number | 7 | 0 |
| Lack of documentation of a substitution, number | Not checked | 4 |
| Wrong strength per unit, number | Not checked | 4 |
| Lack of documentation of a dispensing, number | 0 | 1 |
SD standard deviation
Baseline characteristics: no statistically significant differences between groups were observed
Fig. 2Flow diagram (CONSORT [19])